MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

MET exon 14 splicing mutations are new targetable oncogenic drivers reported in 3% of non-small cell lung cancer (NSCLC) cases and have been shown to be more common in pulmonary sarcomatoid carcinomas (PSCs). This study sought to screen mutations affecting MET exon 14 splice sites in a large SC coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Saffroy, Raphaël, Fallet, Vincent, Girard, Nicolas, Mazieres, Julien, Sibilot, Denis Moro, Lantuejoul, Sylvie, Rouquette, Isabelle, Thivolet-Bejui, Françoise, Vieira, Thibaut, Antoine, Martine, Cadranel, Jacques, Lemoine, Antoinette, Wislez, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522077/
https://www.ncbi.nlm.nih.gov/pubmed/28418914
http://dx.doi.org/10.18632/oncotarget.16403

Ejemplares similares

Ejemplares similares